CRINETICS PHARMACEUTICALS IN's ticker is CRNX and the CUSIP is 22663K107. A total of 116 filers reported holding CRINETICS PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $448,182 | +134.7% | 15,070 | +42.2% | 0.00% | +100.0% |
| Q2 2023 | $190,994 | +9.0% | 10,599 | -2.9% | 0.00% | 0.0% |
| Q1 2023 | $175,279 | -9.8% | 10,914 | +2.8% | 0.00% | 0.0% |
| Q4 2022 | $194,291 | -2.9% | 10,617 | +4.3% | 0.00% | 0.0% |
| Q3 2022 | $200,000 | +6.4% | 10,178 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $188,000 | -23.9% | 10,078 | +15.9% | 0.00% | 0.0% |
| Q4 2021 | $247,000 | – | 8,693 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,375,169 | $76,819,000 | 7.66% |
| RA Capital Management | 1,875,209 | $42,680,000 | 1.84% |
| Perceptive Advisors | 2,587,953 | $58,901,000 | 1.66% |
| EMORY UNIVERSITY | 97,035 | $2,209,000 | 1.55% |
| New Leaf Venture Partners, L.L.C. | 167,700 | $3,817,000 | 1.05% |
| Orbimed Advisors | 1,914,282 | $43,569,000 | 0.67% |
| Opaleye Management Inc. | 73,000 | $1,661,000 | 0.46% |
| Novo Holdings A/S | 135,009 | $3,073,000 | 0.46% |
| Virtus ETF Advisers LLC | 7,934 | $181,000 | 0.38% |
| Eventide Asset Management | 384,000 | $8,740,000 | 0.30% |